Cataracts are often treated via SICS surgery in low- and middle-income countries, which often leads to poorer results due to limited resources and training. A new AI-based tool aims to improve this.
In today’s fast-paced healthcare landscape, efficiency and accuracy are essential in overcoming workload challenges. Pathology laboratories are under pressure to keep up with growing demands, all while ensuring standardised, consistent and high-quality results.
A newly-developed robot can detect medication side-effects in patients after heart arrhythmia treatment faster than a human doctor, while reducing the number of follow-up tests.
A new open-source automated MRI segmentation tool is setting new standards, developers say. It adapts to any new dataset with minimal user intervention, outperforming similar tools.
Sakura Finetek Europe and MEDIPATH, a group of independent French pathologists, announced their collaboration to enhance cancer diagnostics and thus contribute to improved patient therapeutic management. This decision is part of an ongoing commitment to improving the quality of care provided to patients and in response to the significant increase in cancer cases over the last years.
Skills shortages and digitalization, trends in cardiology and oncology, future prospects in laboratory medicine, and healthy aging – these pressing topics are at the forefront of discussions at this year’s Medica Labmed Forum.
Increasing implementation of robotic automation and AI will speed up scientific progress in science laboratories, according to a new study. The experts outline this process across distinctive levels.
Sakura Finetek’s Tissue-Tek Xpress® x120 Rapid Tissue Processor is the only instrument on the market that allows for continuous, rapid processing of both biopsy and larger tissue, resulting in a streamlined histology workflow. Being part of Sakura’s SMART Automation concept, this tissue processing solution is designed to automate manual work and create a continuous flow throughout the lab.
Cologne researchers have developed an AI-based digital pathology platform to enable extremely fast and accurate fully automated analysis of tissue sections from lung cancer patients.
Radiology practices have a high volume of chest X-rays without clinically significant finding, which take up a lot of time. A new AI tool could improve workflows by providing an automatic report.
Companies are joining the focus exhibition of the Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) to present their services and find new connections for further collaboration. The Congress is held on 18-19 November 2024 in Zurich, Switzerland.
From 45 minutes to just a few seconds: A new computer model utilises AI to examine cardiac MRI scans in the four-chamber plane, potentially offering speedy and dependable heart health evaluation.
Staff shortage, financial burdens, and growing demand for care are major challenges for healthcare institutions. The latest Future Health Index report indicates that AI is seen as a key solution.
Embark on a journey of unparalleled efficiency and precision with Sakura Finetek Europe's newest innovation in identification technology: the Tissue-Tek xPrint® LP Laser Cassette Printer.
As AI is playing an increasingly crucial role in the fields of pharmacy and medicine, Pharmaceutical Automation and Digitalisation Congress (AUTOMA+ 2024) welcomes the entire industry value chain to join the roundtable discussion on the innovative strategies that are navigating the future of pharma. The Congress takes place in Zurich, Switzerland, on 18-19 November 2024.
Digital leaders and major players of the whole value chain gather at Pharmaceutical Automation and Digitalisation Congress (AUTOMA+ 2024) to share professional opinion on trends and latest solutions for the pharma digital transformation. Following the long-standing tradition, the Congress is held in the heart of the pharmaceutical industry, Zurich, Switzerland, on 18-19 November 2024.
The Automa+ 2023 congress has brought fascinating insights into the pharmaceutical landscape. This article distills highlights from the congress, illuminating the paradigm-shifting strides that are set to propel the pharmaceutical industry into a future characterized by interconnected, empathetic, and forward-thinking practices.
Today, a large part of all further medical treatments is based on the results of laboratory analyses. The demand for complex test procedures remains high and the challenges for laboratories are growing.
Executive opening panel dedicated to the sustainable digital healthcare ecosystem is the highlight of the Automa 2023 Congress (September, 25-26, Zurich, Switzerland).
